Contribute Try STAT+ Today

BOSTON — Atul Gawande’s new Boston-based health care venture has yet to design any products, but it could be changing the way some employees of Amazon, Berkshire Hathaway, and JPMorgan Chase receive their health care within the year, the venture’s chief operating officer told a federal judge on Thursday.

The venture’s COO, Jack Stoddard, testified for an hour on Thursday at a Boston federal courthouse during a contentious, technical, and unusually long hearing. The hearing was intended to determine the fate of David Smith, a former midlevel executive at Optum. Smith began a new job at Gawande’s venture, referred to in court documents as ABC, earlier in January. Optum is suing to prevent Smith from continuing to work for the new company.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.